Recent advances in the development of histamine H3 antagonists (Q40208576)

18 September 2017

title

Recent advances in the development of histamine H3 antagonists (English)

1 reference

18 September 2017

Michael Berlin

1

1 reference

18 September 2017

Christopher W Boyce

series ordinal

2

1 reference

18 September 2017

language of work or name

English

0 references

publication date

1 June 2007

1 reference

Expert Opinion on Therapeutic Patents

18 September 2017

published in

1 reference

18 September 2017

volume

17

1 reference

18 September 2017

issue

6

1 reference

18 September 2017

page(s)

675-687

1 reference

Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.6.675

Keynote review: histamine H3 receptor antagonists reach out for the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.6.675

Assessment of pharmacology and potential anti-obesity properties of H3 receptor antagonists/inverse agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.6.675

The histamine H3 receptor: from gene cloning to H3 receptor drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.6.675

Molecular aspects of the histamine H3 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.6.675

The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.6.675

Perspectives on cognitive domains, H3 receptor ligands and neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.6.675

The role of histamine and the tuberomamillary nucleus in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.6.675

Histamine H3-receptor isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.6.675

Differences in pharmacological properties of histamine H(3) receptor agonists and antagonists revealed at two human H (3) receptor isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.6.675

Three histamine receptors (H1, H2 and H3) visualized in the brain of human and non-human primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.6.675

Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.6.675

Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.6.675

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.6.675

4-(2-[2-(2(R)-methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and related 2-aminoethylbenzofuran H3 receptor antagonists potently enhance cognition and attention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.6.675

A new class of potent non-imidazole H(3) antagonists: 2-aminoethylbenzofurans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.6.675

BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: Preclinical pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.6.675

Brain histamine and schizophrenia: potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.6.675

Structurally novel histamine H3 receptor antagonists GSK207040 and GSK334429 improve scopolamine-induced memory impairment and capsaicin-induced secondary allodynia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.6.675

The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.6.675

Histamine in the brain: beyond sleep and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.6.675

Evidence for tolerance following repeated dosing in rats with ciproxifan, but not with A-304121.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.6.675

Recent advances in molecular pharmacology of the histamine systems: physiology and pharmacology of histamine H3 receptor: roles in feeding regulation and therapeutic potential for metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.6.675

Therapeutic potential of histamine H3 receptor agonist for the treatment of obesity and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.6.675

Two novel and selective nonimidazole H3 receptor antagonists A-304121 and A-317920: II. In vivo behavioral and neurophysiological characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.6.675

Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.17.6.675

10.1517/13543776.17.6.675

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference